: AstraZeneca says its vaccine trials suggest a promising immune response in older adults — the group at highest risk of COVID-19

No Comments
Uncategorized

Interim results suggest AstraZeneca’s vaccine with the University of Oxford prompts an immune response in both older and younger adults.

Interim results suggest AstraZeneca’s vaccine with the University of Oxford prompts an immune response in both older and younger adults.